You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-atezolizumab

Showing 1 - 25 of 708
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • 89Zr-atezolizumab PET/CT
  • (no location specified)
Feb 22, 2023

Large B-cell Lymphoma Trial in Groningen (89Zr-atezolizumab PET-imaging)

Recruiting
  • Large B-cell Lymphoma
  • 89Zr-atezolizumab PET-imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 15, 2022

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • (no location specified)
May 14, 2023

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)

Active, not recruiting
  • Prostate Cancer
  • 89Zr- DFO-MSTP2109A
  • 89Zr DFO-MSTP2109A
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Cancer Trial in Wuxi (89Zr-NY009)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Multiple Myeloma Trial in Wuxi (89Zr-NY008)

Recruiting
  • Multiple Myeloma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Dec 15, 2022

Pancreatic Cancer Trial in Grand Rapids (NMK89)

Recruiting
  • Pancreatic Cancer
  • Grand Rapids, Michigan
    BAMF Health
Nov 8, 2023

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Jul 26, 2023

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)

Recruiting
  • Melanoma
  • Renal Cell Carcinoma
  • Zirconium 89Zr crefmirlimab berdoxam
  • Hull, United Kingdom
    Castle Hill Hospital
Feb 15, 2023

Rheumatoid Arthritis Trial in San Francisco (89Zr-DFO-CZP)

Suspended
  • Rheumatoid Arthritis
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2022

Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression Trial in Groningen (89Zr-MPDL-3280A-PET scans)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
  • 89Zr-MPDL-3280A-PET scans
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 28, 2022

Lung Cancer, Colorectal Cancer Trial in Saskatoon (50 mg 89Zr-DFO-Nimotuzumab, 1 mg 89Zr-DFO-Nimotuzumab)

Recruiting
  • Lung Cancer
  • Colorectal Cancer
  • 50 mg 89Zr-DFO-Nimotuzumab
  • 1 mg 89Zr-DFO-Nimotuzumab
  • Saskatoon, Saskatchewan, Canada
    Royal University Hospital
May 18, 2022

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)

Recruiting
  • Advanced Solid Tumor
  • 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
  • Amsterdam, Netherlands
  • +1 more
Dec 9, 2022